Alasdair M Gilfillan
Overview
    Explore the profile of Alasdair M Gilfillan including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              71
            
            
              Citations
              3153
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          
        
        
        
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Desai A, Jung M, Olivera A, Gilfillan A, Prussin C, Kirshenbaum A, et al.
  
  
    J Allergy Clin Immunol
    . 2016 Jan;
          137(6):1863-1871.e6.
    
    PMID: 26774658
  
  
          Background: IL-6, levels of which are reported to be increased in association with mastocytosis, asthma, and urticaria, is used in conjunction with stem cell factor to generate CD34(+) cell-derived primary...
      
2.
        
    
    Bandara G, Beaven M, Olivera A, Gilfillan A, Metcalfe D
  
  
    Eur J Immunol
    . 2015 Aug;
          45(11):3034-44.
    
    PMID: 26256265
  
  
          IL-33 released from damaged cells plays a central role in allergic inflammation by acting through its membrane-bound receptor, ST2 receptor (ST2L). IL-33 activity can be neutralized by the soluble spliced...
      
3.
        
    
    Cruse G, Beaven M, Music S, Bradding P, Gilfillan A, Metcalfe D
  
  
    Mol Biol Cell
    . 2015 Feb;
          26(9):1711-27.
    
    PMID: 25717186
  
  
          MS4A family members differentially regulate the cell cycle, and aberrant, or loss of, expression of MS4A family proteins has been observed in colon and lung cancer. However, the precise functions...
      
4.
        
    
    Hox V, Desai A, Bandara G, Gilfillan A, Metcalfe D, Olivera A
  
  
    J Allergy Clin Immunol
    . 2015 Jan;
          135(3):729-36.e5.
    
    PMID: 25553642
  
  
          Background: Clinical observations suggest that anaphylaxis is more common in adult women compared with adult men, although the mechanistic basis for this sex bias is not well understood. Objectives: We...
      
5.
        
    
    Cruse G, Gilfillan A, Smrz D
  
  
    Methods Mol Biol
    . 2014 Nov;
          1220:365-79.
    
    PMID: 25388263
  
  
          Mast cell activation is a central process in the initiation of allergic disorders. As described elsewhere in this volume, this process can be readily monitored by biochemical, antibody-based, and enzyme-based...
      
6.
        
    
    Radinger M, Jensen B, Swindle E, Gilfillan A
  
  
    Methods Mol Biol
    . 2014 Nov;
          1220:307-23.
    
    PMID: 25388259
  
  
          Mediator release from activated mast cells is a major initiator of the symptomology associated with allergic disorders such as anaphylaxis and asthma. Thus, methods to monitor the generation and release...
      
7.
        
    
    Smrz D, Cruse G, Beaven M, Kirshenbaum A, Metcalfe D, Gilfillan A
  
  
    J Immunol
    . 2014 Nov;
          193(12):5924-32.
    
    PMID: 25378594
  
  
          Rictor is a regulatory component of the mammalian target of rapamycin (mTOR) complex 2 (mTORC2). We have previously demonstrated that rictor expression is substantially downregulated in terminally differentiated mast cells...
      
8.
        
    
    Chan E, Bai Y, Kirshenbaum A, Fischer E, Simakova O, Bandara G, et al.
  
  
    J Allergy Clin Immunol
    . 2014 Mar;
          134(1):178-87.
    
    PMID: 24582309
  
  
          Background: Mastocytosis associated with germline KIT activating mutations is exceedingly rare. We report the unique clinicopathologic features of a patient with systemic mastocytosis caused by a de novo germline KIT...
      
9.
        
    
    Siegel A, Stone K, Cruse G, Lawrence M, Olivera A, Jung M, et al.
  
  
    J Allergy Clin Immunol
    . 2013 Nov;
          132(6):1388-96.
    
    PMID: 24184145
  
  
          Background: Severe atopic conditions associated with elevated serum IgE are heterogeneous with few known causes. Nearly every patient with autosomal-dominant hyper-IgE syndrome (AD-HIES) due to signal transducer and activator of...
      
10.
        
    
    Chan E, Bai Y, Bandara G, Simakova O, Brittain E, Scott L, et al.
  
  
    Exp Hematol
    . 2013 Jun;
          41(10):870-881.e2.
    
    PMID: 23743299
  
  
          Stem cell factor-dependent KIT activation is an essential process for mast cell homeostasis. The two major splice variants of KIT differ by the presence or absence of four amino acids...